Cargando…

The Efficacy of Fibrinogen Concentrates in Relation to Cryoprecipitate in Restoring Clot Integrity and Stability against Lysis

Loss of fibrinogen is a feature of trauma-induced coagulopathy (TIC), and restoring this clotting factor is protective against hemorrhages. We compared the efficacy of cryoprecipitate, and of the fibrinogen concentrates RiaSTAP(®) and FibCLOT(®) in restoring the clot integrity in models of TIC. Cryo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Whyte, Claire S., Rastogi, Akriti, Ferguson, Ellis, Donnarumma, Michela, Mutch, Nicola J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949572/ https://www.ncbi.nlm.nih.gov/pubmed/35328366 http://dx.doi.org/10.3390/ijms23062944

Ejemplares similares

Theoretical modelling of fibrinogen supplementation with therapeutic plasma, cryoprecipitate, or fibrinogen concentrate
por: Collins, P. W., et al.
Publicado: (2014)

Cryoprecipitate transfusion in trauma patients attenuates hyperfibrinolysis and restores normal clot structure and stability: Results from a laboratory sub-study of the FEISTY trial
por: Morrow, Gael B., et al.
Publicado: (2022)

Differences in coagulation-relevant parameters: Comparing cryoprecipitate and a human fibrinogen concentrate
por: Stanford, Sophia, et al.
Publicado: (2023)

Citrullinated Fibrinogen Renders Clots Mechanically Less Stable, but Lysis-Resistant
por: Varjú, Imre, et al.
Publicado: (2021)

Randomized comparison of fibrinogen concentrate versus cryoprecipitate for bleeding control in pediatric cardiac surgery (FICCS study)
por: Galas, F, et al.
Publicado: (2012)

Cost-effectiveness of Fibrinogen Concentrate vs Cryoprecipitate for Treating Acquired Hypofibrinogenemia in Bleeding Adult Cardiac Surgical Patients
por: Abrahamyan, Lusine, et al.
Publicado: (2023)

Comparison of Bacterial Risk in Cryo AHF and Pathogen Reduced Cryoprecipitated Fibrinogen Complex
por: Lu, Thea, et al.
Publicado: (2022)

Impact of Fibrinogen Carbamylation on Fibrin Clot Formation and Stability
por: Binder, Veronika, et al.
Publicado: (2017)

A new device for measurement of fibrin clot lysis: application to the Euglobulin Clot Lysis Time
por: Boudjeltia, K Zouaoui, et al.
Publicado: (2002)

Cryoprecipitate therapy
por: Nascimento, B., et al.
Publicado: (2014)

Fibrin Clot Formation and Lysis in Plasma
por: Larsen, Julie Brogaard, et al.
Publicado: (2020)

A Randomized Pilot Trial Assessing the Role of Human Fibrinogen Concentrate in Decreasing Cryoprecipitate Use and Blood Loss in Infants Undergoing Cardiopulmonary Bypass
por: Tirotta, Christopher F., et al.
Publicado: (2022)

Weight-adjusted dosing of fibrinogen concentrate and cryoprecipitate in the treatment of hypofibrinogenaemic bleeding adult cardiac surgical patients: a post hoc analysis of the Fibrinogen Replenishment in cardiac surgery randomised controlled trial
por: Devine, Cian, et al.
Publicado: (2022)

Effect of fibrinogen concentrate on clot strength in trauma: preliminary results of an in vitro study
por: Meyer, MAS, et al.
Publicado: (2012)

Recent advances in use of fresh frozen plasma, cryoprecipitate, immunoglobulins, and clotting factors for transfusion support in patients with hematologic disease
por: Nair, Prajeeda M., et al.
Publicado: (2020)

Influence of canine donor plasma hemostatic protein concentration on quality of cryoprecipitate
por: Drinkhouse, Macy, et al.
Publicado: (2018)

Factors affecting the quality of cryoprecipitate
por: Subramaniyan, Rajeswari, et al.
Publicado: (2017)

Perioperative Cryoprecipitate Waste Reduction
por: Burk, Camden, et al.
Publicado: (2021)

Use of Cryoprecipitate in Newborn Infants
por: Tyagi, Manvi, et al.
Publicado: (2023)

Effect of cryoprecipitate on an increase in fibrinogen level in patients with excessive intraoperative blood loss: a single-center retrospective study
por: Kouroki, Satoshi, et al.
Publicado: (2022)

Cryoprecipitate as an alternative to platelet transfusion in thrombocytopenia
por: Crispin, Philip, et al.
Publicado: (2021)

Platelet factor XIII-A regulates platelet function and promotes clot retraction and stability
por: Mitchell, Joanne L., et al.
Publicado: (2023)

Reduced fibrin clot lysis in Klinefelter syndrome associated with hypogonadism
por: Chang, Simon, et al.
Publicado: (2022)

Thrombin‐generating potential, plasma clot formation, and clot lysis are impaired in patients with bleeding of unknown cause
por: Hofer, Stefanie, et al.
Publicado: (2019)

ON THE NATURE OF FORCES OPERATING IN BLOOD CLOTTING : II. THE CLOTTING OF FIBRINOGEN AS A TWO-STEP REACTION
por: Mommaerts, W. F. H. M.
Publicado: (1945)

Initial Results of Empirical Cryoprecipitate Transfusion in the Treatment of Isolated Severe Traumatic Brain Injury: Use of In-house-produced Cryoprecipitate
por: SHIBAHASHI, Keita, et al.
Publicado: (2019)

Fibrinogen and clot-related phenotypes determined by fibrinogen polymorphisms: Independent and IL-6-interactive associations
por: Cronjé, H. Toinét, et al.
Publicado: (2017)

The association of alcohol with circulating total fibrinogen and plasma clot density is mediated by fibrinogen and FXIII genotypes
por: Rautenbach, Petro Hannie, et al.
Publicado: (2020)

“Super” SERPINs—A stabilizing force against fibrinolysis in thromboinflammatory conditions
por: Humphreys, Steven J., et al.
Publicado: (2023)

Fibrinogen Replacement Therapy for Traumatic Coagulopathy: Does the Fibrinogen Source Matter?
por: Morrow, Gael B., et al.
Publicado: (2021)

Protocol for a phase III, non-inferiority, randomised comparison of a new fibrinogen concentrate versus cryoprecipitate for treating acquired hypofibrinogenaemia in bleeding cardiac surgical patients: the FIBRES trial
por: Karkouti, Keyvan, et al.
Publicado: (2018)

Comparison of coagulation parameters associated with fibrinogen concentrate and cryoprecipitate for treatment of bleeding in patients undergoing cytoreductive surgery for pseudomyxoma peritonei: Subanalysis from a randomized, controlled phase 2 study
por: Roy, Ashok, et al.
Publicado: (2023)

THE LYSIS IN RABBITS OF INTRAVASCULAR BLOOD CLOTS BY THE STREPTOCOCCAL FIBRINOLYTIC SYSTEM (STREPTOKINASE)
por: Johnson, Alan J., et al.
Publicado: (1952)

Development of an in vitro model to study clot lysis activity of thrombolytic drugs
por: Prasad, Sweta, et al.
Publicado: (2006)

Clot Lysis and Antimitotic Study of Ficus glomerata Roxb Fruit Extracts
por: Shivasharanappa, Kirankumar, et al.
Publicado: (2014)

The Occurrence of Thrombosis in Inflammatory Bowel Disease Is Reflected in the Clot Lysis Profile
por: Bollen, Lize, et al.
Publicado: (2015)

Investigating the two regimes of fibrin clot lysis: an experimental and computational approach
por: Raynaud, Franck, et al.
Publicado: (2021)

Citrullinated fibrinogen forms densely packed clots with decreased permeability
por: Varjú, Imre, et al.
Publicado: (2022)

Effects of Post-Translational Modifications of Fibrinogen on Clot Formation, Clot Structure, and Fibrinolysis: A Systematic Review
por: de Vries, Judith J., et al.
Publicado: (2020)

Impact of fibrinogen concentrate alone or with prothrombin complex concentrate (+/− fresh frozen plasma) on plasma fibrinogen level and fibrin-based clot strength (FIBTEM) in major trauma: a retrospective study
por: Schlimp, Christoph J, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_39fr8shlu9ooiervsi5ua2brt9